H.C. Wainwright Maintains Rockwell Medical(RMTI.US) With Buy Rating, Cuts Target Price to $3
Rockwell Medical Is Maintained at Buy by HC Wainwright & Co.
Rockwell Medical Analyst Ratings
Rockwell Medical's Growth Potential Amid Revenue Challenges: A Buy Rating by Ram Selvaraju
Rockwell Medical Analyst Ratings
H.C. Wainwright Maintains Rockwell Medical(RMTI.US) With Buy Rating, Maintains Target Price $7
Strategic Partnerships and Revenue Growth Drive Buy Rating for Rockwell Medical
Rockwell Medical Analyst Ratings
H.C. Wainwright Maintains Rockwell Medical(RMTI.US) With Buy Rating, Cuts Target Price to $7
Rodman & Renshaw Initiates Rockwell Medical(RMTI.US) With Buy Rating, Announces Target Price $5
Rockwell Medical Initiated With a Buy at Rodman & Renshaw
Maxim Group Maintains Rockwell Medical(RMTI.US) With Buy Rating, Maintains Target Price $6
H.C. Wainwright Maintains Rockwell Medical(RMTI.US) With Buy Rating, Maintains Target Price $9
Rockwell Medical Analyst Ratings
H.C. Wainwright Maintains Rockwell Medical(RMTI.US) With Buy Rating, Maintains Target Price $9
Buy Rating Justified by Rockwell Medical's Growth Prospects and Strategic Partnerships
Rockwell Medical Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Rockwell Medical, Maintains $9 Price Target
Rockwell Medical Analyst Ratings
Rockwell Medical: Strong Financial Performance and Strategic Partnerships Justify Buy Rating